Addressing and reversing the harms of drug control in Eastern Europe and Central Asia

The side event will emphasize the importance of better integrating human rights, public health and drug policies in Eastern Europe and Central Asia (EECA). It will also explore possible steps that could facilitate constructive discussions and action by the responsible governmental bodies and non-governmental organisations.

In many EEECA countries there has been insufficient progress in ensuring that all aspects of drug control are addressed in conformity with human rights as part of drug control, despite this commitment appearing repeatedly in CND and General Assembly resolutions, including most recently the outcome document of the UN General Assembly Special Session (UNGASS) in 2016. Meanwhile, the human rights concerns raised by drug control are increasingly the subject of comment by a growing number of international bodies, including the Office of the UN High Commissioner for Human Rights (OHCHR), UN human rights treaty bodies and procedures, UN agencies and even on occasion the International Narcotics Control Board (INCB), which monitors states’ implementation of the UN drug control conventions. Human rights concerns raised in the EECA include establishing proportionate penalties and reducing over-incarceration, ensuring access to justice and due process, freedom of expression, ending discriminatory impacts of drug control enforcement, and realizing the right to health, including ensuring adequate access to controlled substances for pain relief and other medical purposes (such as expanded treatment options for opioid dependence).

Date: Friday, March 17, 2017
Time: 1:00 – 2:00 p.m.
Location: Room MOE100, Vienna International Center (Vienna, Austria)

Addressing and reversing the harms of drug control in Eastern Europe and Central Asia

This entry was posted in Events. Bookmark the permalink. Both comments and trackbacks are currently closed.